Blue Trust Inc’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
Other funds holding BBC
Blue Trust Inc's BBC Position: Q3 2026 in Review
Blue Trust Inc opened a new position in Virtus Biotech Clinical Trials ETF (BBC) in Q3 2026: 6 shares worth $266. The stake represents ﹤0.01% of the portfolio and ranks #2347 among its holdings.
3 funds tracked by Wall St. Rank hold BBC as of Q3 2026.
- Blue Trust Inc held 6 shares of Virtus Biotech Clinical Trials ETF worth $266 as of Q3 2026.
- Virtus Biotech Clinical Trials ETF was a new Blue Trust Inc position in Q3 2026.
- Virtus Biotech Clinical Trials ETF made up ﹤0.01% of Blue Trust Inc's portfolio in Q3 2026, its #2347 holding.
- 3 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2026.
Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.